Open access
Open access
Powered by Google Translator Translator

Genetics & Rare Diseases

ASCO 2018: Many Women with Early-Stage Breast Cancer Can Forgo Chemotherapy When Guided by a 21-Gene Expression Assay

7 Jun, 2018 | 02:23h | UTC

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer – New England Journal of Medicine (free)

Commentaries: 2018 ASCO: TAILORx: Most Women With Early-Stage Breast Cancer Can Forgo Chemotherapy When Guided by a Diagnostic Test – The ASCO Post (free) AND Many breast cancer patients can skip chemo, big study finds – STAT (free) AND Many women with early-stage breast cancer can skip chemotherapy: study – Reuters (free) AND For Some Breast Cancer Patients, The Chemo Decision Just Got Easier – NPR (free) AND Breast cancer: Test means fewer women will need chemotherapy – BBC (free) AND Good News for Women With Breast Cancer: Many Don’t Need Chemo – The New York Times (10 articles per month are free)

 


ASCO 2018: Matching Treatment to Genetic Changes in the Tumor Improves Survival Across Multiple Cancer Types

6 Jun, 2018 | 21:31h | UTC

Matching treatment to genetic changes in the tumour improves survival across multiple cancer types – ASCO, via eCancer News (free)

 


New Therapy Assessed for Children with X-Linked Hypophosphatemia

29 May, 2018 | 18:27h | UTC

Burosumab Therapy in Children with X-Linked Hypophosphatemia – New England Journal of Medicine (link to abstract – $ for full-text)

Quick Take Video Summary: Burosumab for X-Linked Hypophosphatemia (free)

 


Perspective: Can Genetic Counselors Keep Up With 23andMe?

28 May, 2018 | 12:29h | UTC

Can Genetic Counselors Keep Up With 23andMe? – The Atlantic (free)

 


Perspective: p53 and Me

24 May, 2018 | 22:58h | UTC

p53 and Me – New England Journal of Medicine (free)

 


Randomized Controlled Trial: Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

23 May, 2018 | 12:13h | UTC

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Autoinflammatory Syndromes Show Dramatic Response to Canakinumab – RheumNow (free)

 


Guideline: Clinical Management of Niemann-Pick Disease Type C

21 May, 2018 | 13:06h | UTC

Consensus clinical management guidelines for Niemann-Pick disease type C – Orphanet Journal of Rare Diseases (free)

Source: New Clinical Practice Guidelines, May 2018 Edition – Medscape (free registration required)

 


Opinion: Implications of Direct-to-Consumer Genetic Testing for BRCA Mutation

21 May, 2018 | 13:05h | UTC

Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing – JAMA (free for a limited period)

 


Perspective: Can the U.S. Get 1 Million People to Volunteer Their Genomes?

4 May, 2018 | 01:45h | UTC

Can the U.S. Get 1 Million People to Volunteer Their Genomes? – Scientific American (free)

Source: Global Health NOW Newsletter

 


Viewpoint: In the Era of Precision Medicine and Big Data, Who Is Normal?

3 May, 2018 | 20:02h | UTC

Viewpoint: In the Era of Precision Medicine and Big Data, Who Is Normal? – JAMA (free for a limited period)

 


Study Identifies 44 Genetic Risk Factors for Depression

27 Apr, 2018 | 01:15h | UTC

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression – Nature Genetics (link to abstract – $ for full-text)

Commentaries: Unprecedented study identifies 44 genetic risk factors for major depression – King’s College London, via MedicalXpress (free) AND ‘Gene map for depression’ sparks hopes of new generation of treatments – The Guardian (free) AND Global study finds 44 genetic risk factors for major depression – Reuters (free)

 


Perspective: In the Era of Precision Medicine and Big Data, Who Is Normal?

25 Apr, 2018 | 13:44h | UTC

In the Era of Precision Medicine and Big Data, Who Is Normal? – JAMA (free for a limited period)

 


Research :Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

20 Apr, 2018 | 01:57h | UTC

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia – New England Journal of Medicine (free)

Editorial: Gene Therapy as a Curative Option for β-Thalassemia (free)

Quick Take Video Summary: LentiGlobin Gene Therapy for β-Thalassemia (free)

Commentaries: Gene therapy could free some people from a lifetime of blood transfusions – MIT Technology Review (free) AND Gene Therapy For Inherited Blood Disorder Reduced Transfusions – NPR (free) AND Expert reaction to study on gene therapy for beta-thalassaemia – Science Media Centre (free)

 


Parenting of the future: Many embryos, each with DNA profile

20 Apr, 2018 | 00:57h | UTC

Parenting of the future: Many embryos, each with DNA profile – Associated Press (free)

 


Perspective: the rise of the genetic risk score in cardiovascular disease

3 Apr, 2018 | 16:03h | UTC

Cardiovascular disease: The rise of the genetic risk score – PLOS Medicine (free) (via @EricTopol see Tweet)

 


Perspective: the struggle to build a massive ‘biobank’ of patient data

3 Apr, 2018 | 15:59h | UTC

The Struggle to Build a Massive ‘Biobank’ of Patient Data – The New York Times (10 articles per month are free)

 


The Struggle to Build a Massive ‘Biobank’ of Patient Data

30 Mar, 2018 | 03:11h | UTC

The Struggle to Build a Massive ‘Biobank’ of Patient Data – The New York Times (10 articles per month are free)

 


Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings

30 Mar, 2018 | 03:05h | UTC

Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial – Genetics in Medicine (free PDF for a limited period)

Commentary: Sequencing patients’ genomes might not break the health care bank, study finds – STAT News (free)

 


Viewpoint: Precision Medicine, Genome Sequencing, and Improved Population Health

22 Mar, 2018 | 23:41h | UTC

Viewpoint: Precision Medicine, Genome Sequencing, and Improved Population Health – JAMA (free for a limited period)

 


Opinion: At-home genetic testing may be convenient, but it isn’t complete

16 Mar, 2018 | 01:27h | UTC

At-home genetic testing may be convenient, but it isn’t complete – STAT (free)

 


Crispr gene editing ready for testing in humans

16 Mar, 2018 | 01:19h | UTC

Crispr gene editing ready for testing in humans – Financial Times (free for a limited period)

Source: Medical Futurist Newsletter

 


With new CRISPR inventions, its pioneers say, you ain’t seen nothin’ yet

1 Mar, 2018 | 22:04h | UTC

With new CRISPR inventions, its pioneers say, you ain’t seen nothin’ yet – STAT (free)

 


Recommendations for the detection and diagnosis of Niemann-Pick disease type C

1 Mar, 2018 | 21:56h | UTC

Recommendations for the detection and diagnosis of Niemann-Pick disease type C – Neurology Clinical Practice (free)

 


Research: Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy

22 Feb, 2018 | 22:50h | UTC

Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: Noncompaction Cardiomyopathy Outcomes – American College of Cardiology, Latest in Cardiology (free)

 


The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants

22 Feb, 2018 | 21:42h | UTC

The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants – Canadian Medical Association Journal (free)

Commentaries: Cracks in the code: Why mapping your DNA may be less reliable than you think – The Globe and Mail (free) AND Genomics has entered its adolescent phase: messy and unpredictable – The Globe and Mail (free) AND University of Toronto News (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.